RBC Capital Maintains Sector Perform on PTC Therapeutics, Raises Price Target to $82

RBC Capital analyst Brian Abrahams maintains PTC Therapeutics (NASDAQ:PTCT) with a Sector Perform and raises the price target from $81 to $82.